TMO (TMO) Stock Analysis

TMO (TMO) is a publicly traded company in the HEALTHCARE sector. It trades at $482.01, carries a market capitalization of $183.60B, a price-to-earnings ratio of 27.17. This page summarizes the public market data, fundamentals, and frequently asked questions for TMO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NYSE

Key Metrics

• Price: $482.01
• Market Cap: $183.60B
• P/E Ratio: 27.17
• EPS: $18.18
• 52-Week High: $643.35
• 52-Week Low: $384.44

Market Sentiment

TMO currently has a Bullish sentiment score of 0.27.

About TMO

Thermo Fisher Scientific Inc. (TMO) is a leading global provider of scientific instrumentation, reagents, consumables, and software, delivering essential solutions across healthcare, life sciences, and research laboratories in academia, government, and the industrial sectors, including biotechnology and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company emerged in 2006 from the merger of Thermo Electron and Fisher Scientific, positioning itself at the forefront of innovatio...

GNG Research Analysis

GNG Research scores TMO (TMO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TMO.

Frequently Asked Questions

Does TMO pay dividends?

TMO (TMO) does not currently pay a regular dividend.

What is TMO's P/E ratio?

TMO has a price-to-earnings (P/E) ratio of 27.17.

What is TMO's market cap?

TMO (TMO) has a market capitalization of $183.60B with a current stock price of $482.01.